iPredict, an automated artificial intelligence (AI) retinal screening system, has received CE certification and Australian approval for early detection of age-related macular degeneration (AMD),
US researchers have found that experimental drug 32-134D, previously shown to slow liver tumour growth in mice, could halt proliferative diabetic retinopathy (PDR) and diabetic macular oedema (DMO) in
An Australian study found coffee and tea drinkers had significantly improved macular retinal nerve fibre layer thickness (mRNFL), a marker of neurodegeneration. Researchers led by Centre for Eye
Wellington-based ophthalmic distribution company Medix 21 has teamed up with UK intraocular lens (IOL) manufacturer Rayner and Kiwi health intelligence company CatTrax to offset the carbon footprint
The Optometrists and Dispensing Opticians Board (ODOB) has published its first workforce survey report, highlighting a young, positive and mostly female profession challenged by an uneven geographical distribution and under-representation of Māori and Pasifika.
In a post-Budget 2023 interview in the NZ Herald, Dr Ayesha Verrall, minister of health and of research, science and innovation, said clinicians including ophthalmologists will have “the opportunity to really get their hands much closer to the levers of how we run the health system” to tackle the ‘p
King Charles III’ first birthday honours have recognised the achievements of several Australian eyecare professionals.
The Royal Australian and New Zealand College of Ophthalmologists (RANZCO) has written to its New Zealand members urging them not to train experienced hospital optometrists to do minor laser
Driven by strong population growth in the Bay of Plenty, Tauranga Eye Specialists is expanding with a new two-theatre clinic expected to open in Papamoa early next year.
A blind Iranian-American politician has bowed out of public office to serve as a Jesuit novice and live a life of poverty, chastity and obedience.
A new study found elevated gamma-glutamyl transferase (GGT) levels (commonly used as an indicator of liver dysfunction and alcohol consumption) were associated with increased atherosclerotic
Sun Pharma’s Cequa (ciclosporin 900μg/ml) eyedrop has been listed on Australia’s Pharmaceutical Benefits Scheme (PBS) for patients with chronic, severe dry eye disease (DED) with keratitis. Cequa’s